Trademark Overview
On Tuesday, September 26, 2006, a trademark application was filed for OZATIQ with the United States Patent and Trademark Office. The USPTO has given the OZATIQ trademark a serial number of 77007684. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, March 2, 2007. This trademark is owned by Pfizer Inc. The OZATIQ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital and urological, viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, obesity, pain, sexual dysfunction; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and pharmaceutical preparations that accelerate and enhance bone healing
